Huakang Biomedical Holdings Company Limited (08622)

Director	From	To	Position(s)	Release Date / Document Links	Reason for Change
Bu Su	08-Aug-24		NED
Chan Peter Kin Sang	26-Nov-18	02-Apr-24	INED
Chang Yim Yang			Sen Mgr
Chau Lai Ki	07-Nov-17		CoSec, FC
Cheng Faat Ting Gary		08-Jul-25	ChAC	08-Jul-25	Dr. Cheng intended to devote more time to his other business and personal commitments.
Cheng Gary Faat Ting	01-Sep-20	08-Jul-25	INED	08-Jul-25	Dr. Cheng intended to devote more time to his other business and personal commitments.
Chow Ching Man	02-Aug-23	22-Jan-25	INED	22-Jan-25	Ms. Chow intended to devote more time to her other personal business and commitments.
Chow Joseph Kwok Fai	16-Dec-20		INED
He Jiaming	14-Jan-20	16-Apr-25	ED	16-Apr-25	After discussion with the Board, Mr. He intended to devote more time to focus on the management of the business of the subsidiaries of the Company, rather than to focus on the Company’s executive functions.
Kwok Wilson Chi Shing	26-Nov-18	01-Sep-20	INED
Poon Michael Lai Yin	03-Aug-17		FD
Shih Mei Ling	03-Dec-24	28-Feb-25	INED	28-Feb-25	Ms. Shih resigned as she intended to devote more time to her other personal business and commitments.
Tsui Wing Tak	08-Jul-25		ChAC
Tsui Wing Tak	22-Jan-25		INED
Xu Ming	25-Oct-24		NED
Yeung David Wai Chow	26-Nov-18	16-Dec-20	INED
Zhang Chunguang	03-Aug-17		CEO
Zhang Shuguang	03-Aug-17		Ch
Zhang Shuguang		29-Aug-25	ED	29-Aug-25	Mr. Zhang intended to devote more time to focus on the management of the business of the subsidiaries of the Company, rather than to focus on the Company’s executive functions.